Monday, 1 June 2015

Immunotherapy drug combo curbs melanoma advance

Nivolumab and ipilimumab together stave off progression for up to a year

Related items from OnMedica

Surge in number of skin cancer admissions
Guidance aims to iron out wide variations in melanoma management
Sunlight still causes damage after dark
Melanoma drug is first to be fast tracked under NHS early access scheme
Green light for new drug for advanced skin cancer
via OnMedica News Read More Here.. Lake forest health and fitness http://ift.tt/1AI2Lvd

No comments:

Post a Comment